Please assess the completion status of the following clinical trial:

Trial Title: The ROVO Study: Radial Optic Neurotomy for CVO

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Onset of CVO not longer than 12 months~* On FLA 1. nonperfused - (greater than 10 disc area of nonperfusion) 2. perfused - visual acuity lower than 0.1 Snellen,or 3. perfused with no improvement of visual acuity over 4 weeks)~Exclusion Criteria:~* • Dense cataract\* (grade 3 and 4) which precludes judgement of the fundus.~  * Pregnancy~ * Allergy against Fluoresceine or Indocyanine green~ * Unable to come for follow up visit~ * Presence of other severe retinopathy or~ * Presence of advanced optic atrophy or uncontrolled glaucoma.~ * Visual acuity higher than 0.5 Snellen.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).